Venkys (India) Ltd

- There is no mention of any current or future plans for fundraising through debt or equity in the transcript. - Management indicated that major projects like the AHP project are completed. - For FY'24-25, expected capital expenditure is limited to existing capital investments across poultry, AHP, and oil segments totaling around Rs. 40-50 crores. - No major new capital projects or fundraising activities are planned or disclosed during the call.

- No major new capital projects are planned for FY'24-25 as the significant capital expenditure for the Animal Health Products (AHP) expansion has been completed. - The new AHP plant became operational in January and will start contributing to production and revenue in the current financial year. - Capital expenditure for FY'24-25 is expected to be modest, around Rs. 40-50 crores, covering maintenance and existing units across poultry, AHP, and oil seed segments. - There are no announcements of additional or strategic investments beyond ongoing capacity utilization improvements and existing unit maintenance.

- Poultry division is expected to show positive volume and value growth compared to the last financial year, driven by improving prices and demand (Page 8). - Animal Health Product (AHP) division aims to grow its revenue by over 20% in FY'25, supported by capacity expansion and regulatory compliance of new manufacturing units (Page 7). - The new AHP plant is futuristic and will help grow volumes steadily over 3-5 years; currently, capacity utilization in the new plant is 35-40%, expected to increase gradually (Pages 13-14). - Oil seed division revenues declined from FY'22 but gradual improvement is expected as poultry consumption grows and market conditions normalize; no major revenue growth target disclosed, but consumption-led improvement foreseen (Pages 6-8). - Processed chicken and QSR business is growing, with expansion in franchise outlets and planned marketing expenditures to boost sales (Page 12). - Cross-selling between poultry products and AHP is being leveraged to support growth (Page 13).

- Poultry segment margins are expected to improve in FY'25 due to stable input prices (maize and soya) and better realizations, with growth anticipated from increased volumes and improved industry conditions. - Animal Health Product (AHP) division aims to grow revenues by over 20% in FY'25, supported by new capacity coming onstream and regulatory compliance. - Oil seed segment margins likely to recover gradually but not back to historical highs due to better crop sowing and market factors; growth depends on poultry segment performance. - Overall better performance expected in FY'25 versus FY'24 due to improved poultry prices and operational efficiency. - The company is focusing on growth through capacity utilization improvements, new product development, and franchise expansion in the processed food (QSR) segment. - Management expects quarterly concalls for better investor insights, reflecting confidence in steady progress.

The provided transcript of Venky's Limited conference call dated May 13, 2024, does not contain any specific information or data regarding the current or expected order book or pending orders for the company. The discussion primarily covers topics like balance sheet items, financial performance, segment-wise revenue, commodity prices, capacity utilization, and future outlook for different business segments. There are no mentions or disclosures about outstanding orders or order backlog in the transcript.